Table 1.
Activity of HIV-1 PR mutants
| Level of activity | Substitutions at indicated flap positions
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| M46 | I47 | G48 | G49 | I50 | G51 | G52 | F53 | I54 | K55 | V56 | |
| Wild-type | Val | Ser | Leu | Tyr | Leu | Thr | Thr | ||||
| Trp | Thr | Leu | Val | Asn | Cys | ||||||
| Phe | His | Ile | Ile | ||||||||
| Leu | Gln | Val | Arg | ||||||||
| Arg | Trp | Gln | |||||||||
| Ala | Met | ||||||||||
| Lys | |||||||||||
| Intermediate | |||||||||||
| Nearly wild-type | His | Val | Phe | Val | Ser | ||||||
| Arg | Val | ||||||||||
| In between | Asn | Cys | Asn | Ala | Glu | Cys | |||||
| Ser | Ile | Gly | |||||||||
| Glu | Asp | ||||||||||
| Trp | Arg | ||||||||||
| Nearly negative | Gln | Thr | Gly | ||||||||
| Gly | |||||||||||
| Negative | Pro | Asp | Asp | Trp | Tyr | Leu | Asn | His | Leu | ||
| Ala | Pro | Ala | Asn | Thr | His | Asp | Ile | ||||
| Leu | Asp | Thr | Arg | Lys | Asn | Trp | |||||
| Arg | Ser | Ala | Pro | Asp | Arg | Ser | |||||
| Met | Phe | Trp | Cys | Ala | Lys | Ala | |||||
| Asn | Gln | Ser | Lys | Phe | Gly | Glu | |||||
| Gln | Arg | Gln | Val | Val | Pro | Arg | |||||
| Gly | Val | Lys | Met | Ser | Ala | Lys | |||||
| Tyr | Glu | Met | Phe | Pro | Ser | ||||||
| Glu | Lys | Arg | Ile | Arg | Phe | ||||||
| Ser | Leu | Cys | |||||||||
| Lys | His | Met | |||||||||
| Thr | Gln | ||||||||||
| Leu | |||||||||||
The level of protease activity was assessed based on results from Western analysis. A mutant was considered to have a wild-type level of activity if the Pro–Pol precursor was completely processed. A negative phenotype was assigned when no correct processing to generate either the p66 or p51 form of RT was seen. An intermediate phentoype was assigned when some, but not complete, processing was observed. The intermediate phentoype was further subdivided based on whether the activity was nearly wild-type, nearly negative, or in between. One-letter abbrevations for amino acids are used, followed by the position number.